HMOX1 and acute myeloid leukemia: They found that treating AML and Acute Promyelocytic Leukemia (APL) cells with All-Trans Retinoic Acid (ATRA) inhibits Nrf2 and HO-1 function, thus, resulting in improved cell death [109].